Related Experiment Video
Updated: Jan 23, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Characteristics and Outcomes of Pediatric Patients Supported With Ventricular Assist Device-A Multi-Institutional
Kriti Puri1, Marc M Anders2, Sebastian C Tume2
1Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.
Insights
Pediatric ventricular assist device use is growing, with more patients discharged on support. Congenital heart disease, renal failure, sepsis, stroke, and ECMO increase mortality risk in these children.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Critical Care Medicine
Background:
- Ventricular assist devices (VADs) are increasingly used in pediatric heart failure patients.
- This use is associated with significant morbidity and mortality.
- Understanding outcomes and resource utilization is crucial for improving care.
Purpose of the Study:
- To describe admission outcomes for pediatric patients receiving VAD support.
- To analyze resource utilization in this patient population.
- To identify factors associated with mortality and resource use.
Main Methods:
- Retrospective cohort analysis of the Pediatric Health Information System database (2006-2015).
- Included admissions for patients ≤21 years old with VAD implantation.
- Primary outcome: hospital mortality; secondary outcomes: length of stay and adjusted cost.
Main Results:
- Analyzed 744 VAD implantations in 740 pediatric patients.
- Overall hospital mortality was 25%; 53% received a transplant, 19% were discharged on VAD.
- Factors associated with mortality included congenital heart disease, renal failure, sepsis, stroke, and extracorporeal membrane oxygenation (ECMO).
Conclusions:
- Pediatric VAD use is increasing, with a higher proportion discharged on support in recent years.
- Congenital heart disease, renal failure, sepsis, stroke, and ECMO are significant predictors of hospital mortality.
- Sepsis and VAD replacement/repair correlate with increased costs and longer hospital stays.
Objectives:
The use of ventricular assist devices for pediatric patients with heart failure is increasing, but is associated with significant morbidity and mortality. Our objectives were to describe the admission outcomes and resource utilization of pediatric patients supported with ventricular assist devices, utilizing a multicenter database.
Data Sources:
Pediatric Health Information System database (comprising 49 nonprofit children's hospitals).
Study Selection:
Retrospective cohort analysis of the database from January 2006 to September 2015 for all admissions less than or equal to 21 years old with ventricular assist device implantation.
Data Extraction:
The primary outcome was hospital mortality. The secondary outcomes were hospital length of stay and adjusted cost.
Data Synthesis:
We analyzed 744 ventricular assist device implantations (740 patients), 422 (57%) males, and 363 (49%) non-Hispanic white. Median age at admission was 5.9 years (interquartile range, 0.9-13.5 yr), and median length of stay was 69 days (interquartile range, 36-122 d). The overall hospital mortality was 188 (25%), whereas 395 (53%) were transplanted and 141 (19%) were discharged on ventricular assist device. Extracorporeal membrane oxygenation was used, in addition to ventricular assist device, in 340 (46%). The majority of ventricular assist device implantations (453, 61%) were from 2011 to 2015 (compared to 2006-2010). More patients discharged on ventricular assist device from 2011 to 2015 (23% vs 13% in 2006-2010; p = 0.001). There was no difference in median age, mortality, length of stay, or adjusted costs between these time periods. On multivariable analysis, underlying congenital heart disease, renal failure, liver congestion, sepsis, cerebrovascular accident, and extracorporeal membrane oxygenation were associated with hospital mortality. Sepsis and ventricular assist device replacement/repair were associated with higher adjusted cost and longer length of stay.
Conclusions:
The pediatric ventricular assist device experience continues to grow, with a significant increase in the number of patients undergoing ventricular assist device implantation and a higher proportion being discharged from hospital on ventricular assist device support in recent years. Underlying congenital heart disease, renal failure, sepsis, cerebrovascular accident, and extracorporeal membrane oxygenation are significantly associated with hospital mortality.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Characteristics of Life
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...

